AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 59 filers reported holding AVROBIO INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $331,000 | -77.4% | 23,449 | -73.9% | 0.01% | -78.0% |
| Q2 2019 | $1,463,000 | -33.7% | 90,000 | -10.0% | 0.06% | -34.4% |
| Q1 2019 | $2,205,000 | +32.4% | 100,000 | 0.0% | 0.09% | +45.2% |
| Q4 2018 | $1,665,000 | -67.9% | 100,000 | 0.0% | 0.06% | -54.1% |
| Q3 2018 | $5,187,000 | +45.3% | 100,000 | -20.0% | 0.14% | +77.6% |
| Q2 2018 | $3,570,000 | – | 125,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |